Zdrowie i gospodarka · 30/06/2015

FDA Announces Availability of Draft and Revised Draft Bioequivalence Recommendations

The FDA has released additional product-specific bioequivalence recommendations to support abbreviated new drug applications, building on the 2010 guidance for industry that outlined the process for making these recommendations publicly available.